ReviewNeuroscience bulletin2026
Spatiotemporal Resolution for Neurodegenerative Diseases: Linking Proteinopathy, Cellular Vulnerability, and Disease Trajectories.
Review in Neuroscience bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurodegenerative diseases (NDs) are a heterogeneous group of disorders characterized by selective and progressive degeneration of specific neuronal populations, often accompanied by glial dysfunction. Despite extensive investigation, proposed pathogenic models remain insufficient to fully explain selective vulnerability and stereotyped spatiotemporal patterns of neurodegeneration across diseases. Spatial omics technologies preserve anatomical context and enable interrogation of cell-type composition, molecular heterogeneity, and intercellular interactions within neural systems. In this review, we synthesize current concepts and technological advances in spatial omics and discuss how these approaches are reshaping our understanding of NDs. Spatial omics provides an integrative framework for linking pathological protein aggregation with selective cellular vulnerability, microenvironment-dependent interactions, and disease progression across molecular, cellular, and anatomical scales. We highlight emerging insights into pathology-associated gene modules, neuron-glia interactions, and mechanisms underlying regional vulnerability. Finally, we discuss multimodal data integration and future directions for translating spatially resolved molecular maps into mechanistic understanding.
Indexed as
Identifiers
42920062What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.